Page last updated: 2024-11-07

beta-hydroxyleucine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

beta-hydroxyleucine: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6994741
SCHEMBL ID497774
MeSH IDM0082976

Synonyms (23)

Synonym
AC-967
DB02978
beta-hydroxyleucine
(2s,3s)-2-amino-3-hydroxy-4-methylpentanoic acid
(2s,3s)-3-hydroxyleucine
10148-70-6
(2s,3s)-2-amino-3-hydroxy-4-methyl-pentanoic acid
AKOS006312021
l-leucine, 3-hydroxy-, (3s)-
SCHEMBL497774
DTXSID90426396
mfcd09842579
J-000410
AC-1813
3(s)-hydroxyl-l-leucine
(2s,3s)-2-amino-3-hydroxy-4-methyl-valeric acid
(2s,3s)-2-amino-3-hydroxy-4-methylpentanoic acid (non-preferred name)
Q27093948
AS-30750
A848706
2-amino-3-hydroxy-4-methyl-pentanoic acid;(2s,3s)-3-hydroxyleucine
(2s,3s)-2-amino-3-hydroxy-4-methylpentanoicacid
CS-0171927
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (62.50)18.7374
1990's2 (25.00)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]